Novel pyrrolo[2,3-d]pyrimidine derivatives: Design, synthesis, structure elucidation and in vitro anti-BVDV activity

被引:32
作者
Sroor, Farid M. [1 ]
Basyouni, Wahid M. [1 ]
Tohamy, Wael M. [1 ]
Abdelhafez, Tawfeek H. [2 ]
El-awady, Mostafa K. [2 ]
机构
[1] Natl Res Ctr, Organometall & Organometalloid Chem Dept, Cairo 12622, Egypt
[2] Natl Res Ctr, Microbial Biotechnol Dept, Cairo, Egypt
关键词
4,6-Dichloro-pyrrolo[2,3-d]pyrimidine; 2-Trichloromethylpyrrolopyrimidines; Anti-BVDV; SAR; CARBONIC-ANHYDRASE INHIBITORS; PYRROLE; PYRROLOPYRIMIDINES; SULFONAMIDES; MOIETIES; PROTEASE; CANCER; SAR;
D O I
10.1016/j.tet.2019.130749
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
The progression of drug resistance of viral infection justifies the discovering of new anti-viral agents. Thus, a novel series of pyrrolopyrimidine derivatives 5-7 and 9-18 were designed, synthesized and fully characterized by IR, mass spectroscopy, NMR, and elemental analysis. The structure of 4,6-dichloropyrrolo[2,3-d]pyrimidine 10 elucidated by single crystal X-ray diffraction. Herein, we reported the first pyrrolo[2,3-d]pyrimidine compounds with trichloromethane at position 2 of the pyrimidine ring. As initial biological activity screening, evaluation of the pyrrolo[2,3-d]pyrimidine compounds as anti-BVDV (Bovine Viral Diarrhea Virus) was examined. The compounds 11,13,16 and 17 exhibited excellent activity as a potent inhibitor against BVDV. Structure activity relationship showed that the pyrrolo[2,3-d]pyrimidine molecules presenting hydrogen atom or trichloromethyl group on C2 and chlorine, sulfur, pyrrolidine or methoxy groups on C4 of the pyrimidine ring showed high activity as anti-BVDV in comparison with the compounds which have CI or CH3 on C2 position. (C) 2019 Elsevier Ltd. All rights reserved.
引用
收藏
页数:10
相关论文
共 45 条
  • [21] Mosaad S. M., 2010, EUR J MED CHEM, V45, P2994
  • [22] Novel 7H-pyrrolo[2,3-d]pyrimidine derivatives as potent and orally active STAT6 inhibitors
    Nagashima, Shinya
    Hondo, Takeshi
    Nagata, Hiroshi
    Ogiyama, Takashi
    Maeda, Jun
    Hoshii, Hiroaki
    Kontani, Toru
    Kuromitsu, Sadao
    Ohga, Keiko
    Orita, Masaya
    Ohno, Kazuki
    Moritomo, Ayako
    Shiozuka, Koichi
    Furutani, Masako
    Takeuchi, Makoto
    Ohta, Mitsuaki
    Tsukamoto, Shin-Ichi
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (19) : 6926 - 6936
  • [23] The imidazopyrrolopyridine analogue AG110 is a novel, highly selective inhibitor of pestiviruses that targets the viral RNA-dependent RNA polymerase at a hot spot for inhibition of viral replication
    Paeshuyse, Jan
    Chezal, Jean-Michel
    Froeyen, Matheus
    Leyssen, Pieter
    Dutartre, Helene
    Vrancken, Robert
    Canard, Bruno
    Letellier, Carine
    Li, Tong
    Mittendorfer, Harald
    Koenen, Frank
    Kerkhofs, Pierre
    De Clercq, Erik
    Herdewijn, Piet
    Puerstinger, Gerhard
    Gueiffier, Alain
    Chavignon, Olivier
    Teulade, Jean-Claude
    Neyts, Johan
    [J]. JOURNAL OF VIROLOGY, 2007, 81 (20) : 11046 - 11053
  • [24] Pyrrolopyrimidines: An update on recent advancements in their medicinal attributes
    Pathania, Shelly
    Rawal, Ravindra K.
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 157 : 503 - 526
  • [25] Microwave-induced selective synthesis of α-bromo and α,α-dibromoalkanones using dioxane-dibromide and silica gel under solvent-free conditions
    Paul, S
    Gupta, V
    Gupta, R
    Loupy, A
    [J]. TETRAHEDRON LETTERS, 2003, 44 (03) : 439 - 442
  • [26] HR+, HER2-Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of Action, Clinical Activity, and Safety Profiles
    Sammons, Sarah L.
    Topping, Donna L.
    Blackwell, Kimberly L.
    [J]. CURRENT CANCER DRUG TARGETS, 2017, 17 (07) : 637 - 649
  • [27] A short history of SHELX
    Sheldrick, George M.
    [J]. ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2008, 64 : 112 - 122
  • [28] Kinases inhibitors in lung cancer: From benchside to bedside
    Singh, Pankaj Kumar
    Singh, Harpreet
    Silakari, Om
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2016, 1866 (01): : 128 - 140
  • [29] Facile Synthesis, Structural Activity Relationship, Molecular Modeling and In Vitro Biological Evaluation of New Urea Derivatives with Incorporated Isoxazole and Thiazole Moieties as Anticancer Agents
    Sroor, Farid M.
    Abdelmoniem, Amr M.
    Abdelhamid, Ismail A.
    [J]. CHEMISTRYSELECT, 2019, 4 (34): : 10113 - 10121
  • [30] Synthesis, structural characterization and in vivo anti-diabetic evaluation of some new sulfonylurea derivatives in normal and silicate coated nanoparticle forms as anti-hyperglycemic agents
    Sroor, Farid M.
    Abbas, Samir Y.
    Basyouni, Wahid M.
    El-Bayouki, Khairy A. M.
    El-Mansy, Mohamed F.
    Aly, Hanan F.
    Ali, Sanaa A.
    Arafa, Azza F.
    Haroun, Ahmed A.
    [J]. BIOORGANIC CHEMISTRY, 2019, 92